Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

Mesenchymal tumor subpopulations secrete pro-tumorigenic cytokines and promote treatment resistance(1–4). This phenomenon has been implicated in chemorefractory small cell lung cancer (SCLC) and resistance to targeted therapies(5–8), but remains incompletely defined. Here we identify a subclass of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Cañadas, Israel, Thummalapalli, Rohit, Kim, Jong Wook, Kitajima, Shunsuke, Jenkins, Russell William, Christensen, Camilla Laulund, Campisi, Marco, Kuang, Yanan, Zhang, Yanxi, Gjini, Evisa, Zhang, Gao, Tian, Tian, Sen, Debattama Rai, Miao, Diana, Imamura, Yu, Thai, Tran, Piel, Brandon, Terai, Hideki, Aref, Amir Reza, Hagan, Timothy, Koyama, Shohei, Watanabe, Masayuki, Baba, Hideo, Adeni, Anika Elise, Lydon, Christine Anne, Tamayo, Pablo, Wei, Zhi, Herlyn, Meenhard, Barbie, Thanh Uyen, Uppaluri, Ravindra, Sholl, Lynnette Marie, Sicinska, Ewa, Sands, Jacob, Rodig, Scott, Wong, Kwok Kin, Paweletz, Cloud Peter, Watanabe, Hideo, Barbie, David Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082722/
https://www.ncbi.nlm.nih.gov/pubmed/30038220
http://dx.doi.org/10.1038/s41591-018-0116-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082722/
https://www.ncbi.nlm.nih.gov/pubmed/30038220
http://dx.doi.org/10.1038/s41591-018-0116-5

Ejemplares similares